Business Context and Reporting Period
Company: Ocular Therapeutix, Inc. (OCUL)
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2019
Reporting Period: Quarter ended September 30, 2019
Context: The filing serves to announce financial results for the third quarter of 2019. The detailed results are contained in a press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. The filing states that the full financial results are located in the attached press release (Exhibit 99.1). Consequently, the following metrics are not available in the source text:
- Revenue
- Net Profit/Loss
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Position
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not disclose specific material changes or comparative data versus the prior period. It only confirms the announcement of results for the quarter ended September 30, 2019.
Guidance, Outlook, and Risks
Guidance and Outlook: No specific guidance or forward-looking statements are included in the provided text.
Risks and Contingencies: The filing includes a standard disclaimer stating that the information furnished to comply with Item 2.02 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor incorporated by reference in other filings except as expressly set forth.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 12, 2019) for actual revenue, net loss, and cash position figures.
- Verify the company's status as an Emerging Growth Company and its election not to use the extended transition period for new accounting standards.
- Confirm the trading symbol OCUL on the Nasdaq Global Select Market.
- Check subsequent filings for any updates to the financial data announced in this report.